Patents by Inventor Helen J. Hathaway

Helen J. Hathaway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition and treatment of bacterial infections by sex-specific GPER targeting
    Patent number: 10561648
    Abstract: The present invention is directed to the use of compounds which are modulators of the G protein-Coupled Estrogen Receptor (GPER) for the inhibition —and/or treatment of Bacterial infections, especially including metMctHin-resistant Staphylococcus aureus (MRSA) infections. Pharmaceutical compositions and methods of treatment of bacterial pathogens, including MRSA are also described.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: February 18, 2020
    Assignee: STC.UNM
    Inventors: Pamela Hall, Eric R. Prossnitz, Helen J. Hathaway
  • INHIBITION AND TREATMENT OF BACTERIAL INFECTIONS BY SEX-SPECIFIC GPER TARGETING
    Publication number: 20190000830
    Abstract: The present invention is directed to the use of compounds which are modulators of the G protein-Coupled Estrogen Receptor (GPER) for the inhibition—and/or treatment of Bacterial infections, especially including metMctHin-resistant Staphylococcus aureus (MRSA) infections. Pharmaceutical compositions and methods of treatment of bacterial pathogens, including MRSA are also described.
    Type: Application
    Filed: January 9, 2017
    Publication date: January 3, 2019
    Inventors: Pamela Hall, Eric R. Prossnitz, Helen J. Hathaway